Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
HKD 26.85
(-1.65%)
HKD 26.85
(-1.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.33 Billion CNY | 3.77% |
| 2022 | -2.42 Billion CNY | 13.3% |
| 2021 | -2.79 Billion CNY | 6.34% |
| 2020 | -2.98 Billion CNY | 5.93% |
| 2019 | -3.17 Billion CNY | -126.35% |
| 2018 | -1.4 Billion CNY | 20.35% |
| 2017 | -1.75 Billion CNY | 11.28% |
| 2016 | -1.98 Billion CNY | 8.92% |
| 2015 | -2.17 Billion CNY | -1100.93% |
| 2014 | -181.34 Million CNY | 8.01% |
| 2013 | -197.13 Million CNY | -22.59% |
| 2012 | -160.81 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.24 Billion CNY | 9.03% |
| 2024 Q1 | -2.46 Billion CNY | -5.68% |
| 2023 Q3 | -2.37 Billion CNY | 8.48% |
| 2023 FY | -2.33 Billion CNY | 3.77% |
| 2023 Q1 | 2.76 Billion CNY | 214.07% |
| 2023 Q2 | -2.59 Billion CNY | -194.03% |
| 2023 Q4 | -2.33 Billion CNY | 1.97% |
| 2022 Q4 | -2.42 Billion CNY | 4.65% |
| 2022 Q3 | -2.54 Billion CNY | 6.61% |
| 2022 Q2 | -2.72 Billion CNY | 0.5% |
| 2022 Q1 | -2.73 Billion CNY | 2.15% |
| 2022 FY | -2.42 Billion CNY | 13.3% |
| 2021 Q1 | -3.08 Billion CNY | -3.29% |
| 2021 Q2 | -3.07 Billion CNY | 0.39% |
| 2021 Q3 | -2.81 Billion CNY | 8.39% |
| 2021 Q4 | -2.79 Billion CNY | 0.64% |
| 2021 FY | -2.79 Billion CNY | 6.34% |
| 2020 Q3 | -2.9 Billion CNY | 2.82% |
| 2020 FY | -2.98 Billion CNY | 5.93% |
| 2020 Q1 | 3.23 Billion CNY | 201.9% |
| 2020 Q4 | -2.98 Billion CNY | -2.57% |
| 2020 Q2 | -2.99 Billion CNY | -192.61% |
| 2019 Q4 | -3.17 Billion CNY | 0.0% |
| 2019 FY | -3.17 Billion CNY | -126.35% |
| 2019 Q2 | -1.45 Billion CNY | -199.63% |
| 2019 Q1 | 1.45 Billion CNY | 204.09% |
| 2018 Q2 | -1.34 Billion CNY | 0.0% |
| 2018 Q4 | -1.4 Billion CNY | 0.0% |
| 2018 Q1 | -1.34 Billion CNY | 23.59% |
| 2018 Q3 | -1.4 Billion CNY | -4.24% |
| 2018 FY | -1.4 Billion CNY | 20.35% |
| 2017 Q3 | -1.75 Billion CNY | -2.74% |
| 2017 FY | -1.75 Billion CNY | 11.28% |
| 2017 Q1 | -1.71 Billion CNY | 13.71% |
| 2017 Q2 | -1.71 Billion CNY | -0.08% |
| 2017 Q4 | -1.75 Billion CNY | 0.0% |
| 2016 Q1 | -2.16 Billion CNY | 0.77% |
| 2016 Q3 | -1.98 Billion CNY | 8.21% |
| 2016 Q2 | -2.16 Billion CNY | 0.0% |
| 2016 FY | -1.98 Billion CNY | 8.92% |
| 2016 Q4 | -1.98 Billion CNY | 0.0% |
| 2015 Q3 | -2.17 Billion CNY | -298.57% |
| 2015 Q2 | -546.4 Million CNY | 0.0% |
| 2015 Q1 | -546.4 Million CNY | -201.31% |
| 2015 FY | -2.17 Billion CNY | -1100.93% |
| 2015 Q4 | -2.17 Billion CNY | 0.0% |
| 2014 Q1 | -198.65 Million CNY | -0.77% |
| 2014 FY | -181.34 Million CNY | 8.01% |
| 2014 Q3 | -181.34 Million CNY | 8.71% |
| 2014 Q2 | -198.65 Million CNY | 0.0% |
| 2014 Q4 | -181.34 Million CNY | 0.0% |
| 2013 Q3 | -197.13 Million CNY | 0.0% |
| 2013 Q4 | -197.13 Million CNY | 0.0% |
| 2013 Q1 | 167.81 Million CNY | 0.0% |
| 2013 FY | -197.13 Million CNY | -22.59% |
| 2012 FY | -160.81 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | -2953.661% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 144.278% |